Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Break repair meiotic recombinase recruitment factor 1 (BRME1) is a protein coding gene essential for meiotic double-strand break repair. It plays a central role in homologous recombination during meiosis, specifically by modulating the localization and stabilization of recombinases (DMC1:RAD51) to meiotic double-strand break (DSB) sites through interactions with and stabilization of the BRCA2:HSF2BP complex. This function is critical for homologous synapsis, crossover formation, and progression of spermatogenesis, thereby affecting male fertility. Loss or dysfunction of BRME1 is associated with impaired meiotic DSB repair, leading to developmental disorders and infertility. BRME1 does not currently have a known therapeutic targeting profile or any approved interacting drugs[1][3][7][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Break repair meiotic recombinase recruitment factor 1 (BRME1).